Abbott Laboratories is facing scrutiny after a Missouri jury ruled against them. The company must pay $495 million for claims its infant formula caused necrotizing enterocolitis (NEC). This case raises serious safety concerns about Abbott's baby formulas, particularly Similac. Investors reacted negatively, causing Abbott's stock price to drop amid ongoing legal issues. With around 1,000 lawsuits pending, both Abbott and Reckitt Benckiser may experience significant financial challenges.

свернуть